KR20140104474A - 종양 성장의 억제 또는 예방에 사용하기 위한 오스테오폰틴 변이체 및 상기 오스테오폰틴 변이체를 함유하는 조성물 - Google Patents

종양 성장의 억제 또는 예방에 사용하기 위한 오스테오폰틴 변이체 및 상기 오스테오폰틴 변이체를 함유하는 조성물 Download PDF

Info

Publication number
KR20140104474A
KR20140104474A KR1020147018717A KR20147018717A KR20140104474A KR 20140104474 A KR20140104474 A KR 20140104474A KR 1020147018717 A KR1020147018717 A KR 1020147018717A KR 20147018717 A KR20147018717 A KR 20147018717A KR 20140104474 A KR20140104474 A KR 20140104474A
Authority
KR
South Korea
Prior art keywords
opn
seq
variant
cancer
molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020147018717A
Other languages
English (en)
Korean (ko)
Inventor
수산 알 리트링
피터 랑보르그 웨즈세
안자 세레나
Original Assignee
포사이스 덴탈 인퍼머리 포 칠드런 (디.비.에이. 더 포사이스 인스티튜트)
아를라 푸즈 에이엠비에이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 포사이스 덴탈 인퍼머리 포 칠드런 (디.비.에이. 더 포사이스 인스티튜트), 아를라 푸즈 에이엠비에이 filed Critical 포사이스 덴탈 인퍼머리 포 칠드런 (디.비.에이. 더 포사이스 인스티튜트)
Publication of KR20140104474A publication Critical patent/KR20140104474A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1020147018717A 2011-12-07 2012-12-07 종양 성장의 억제 또는 예방에 사용하기 위한 오스테오폰틴 변이체 및 상기 오스테오폰틴 변이체를 함유하는 조성물 Withdrawn KR20140104474A (ko)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201161567899P 2011-12-07 2011-12-07
US61/567,899 2011-12-07
US201261673912P 2012-07-20 2012-07-20
US61/673,912 2012-07-20
EP12177329 2012-07-20
EP12177329.5 2012-07-20
PCT/US2012/068628 WO2013086459A1 (en) 2011-12-07 2012-12-07 Osteopontin variants for use in suppression or prevention of tumor growth and compositions containing such osteopontin variants

Publications (1)

Publication Number Publication Date
KR20140104474A true KR20140104474A (ko) 2014-08-28

Family

ID=48574961

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020147018717A Withdrawn KR20140104474A (ko) 2011-12-07 2012-12-07 종양 성장의 억제 또는 예방에 사용하기 위한 오스테오폰틴 변이체 및 상기 오스테오폰틴 변이체를 함유하는 조성물

Country Status (12)

Country Link
US (1) US20150344534A1 (OSRAM)
EP (1) EP2788015A1 (OSRAM)
JP (1) JP2015500836A (OSRAM)
KR (1) KR20140104474A (OSRAM)
CN (1) CN104080472A (OSRAM)
AR (1) AR089136A1 (OSRAM)
AU (1) AU2012347468A1 (OSRAM)
BR (1) BR112014013565A2 (OSRAM)
CA (1) CA2858379A1 (OSRAM)
EA (1) EA201491010A1 (OSRAM)
WO (1) WO2013086459A1 (OSRAM)
ZA (1) ZA201404920B (OSRAM)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014286123B2 (en) * 2013-07-05 2019-02-28 Arla Foods Amba Mammalian milk osteopontin for enhancing immune responsiveness
EP4326758A4 (en) * 2021-04-20 2025-03-19 University of Cincinnati A vaccine adjuvant for infectious diseases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5888552A (en) * 1988-04-29 1999-03-30 Immunotec Research Corporation Ltd. Anti-cancer therapeutic compositions containing whey protein concentrate
IL106576A (en) * 1992-08-13 2000-08-13 Immunotec Res Corp Ltd Anti-cancer therapeutic compositions for prophylaxis or for treatment of cancer
AU773350B2 (en) * 1999-04-15 2004-05-20 Children's Medical Center Corporation Methods and compositions for modulating an immune response
US7259243B2 (en) * 2000-01-07 2007-08-21 Arla Foods Amba Process for isolation of osteopontin from milk
NZ507335A (en) * 2000-10-05 2004-10-29 New Zealand Dairy Board Bone health compositions derived from milk comprising an acidic protein fraction but that does not contain CGMP
RU2379975C2 (ru) * 2003-09-18 2010-01-27 Арла Фудс Амба Добавка в состав для детского питания
SM200600031B (it) * 2006-10-06 2009-05-11 Gianluca Mech Integratore alimentare con attivatore proteico
ES2538362T3 (es) * 2007-10-16 2015-06-19 Ventana Medical Systems, Inc. Clasificación, estadificación y pronóstico del cáncer mediante el uso de osteopontina-C

Also Published As

Publication number Publication date
EP2788015A1 (en) 2014-10-15
US20150344534A1 (en) 2015-12-03
WO2013086459A1 (en) 2013-06-13
AU2012347468A1 (en) 2014-06-26
AR089136A1 (es) 2014-07-30
ZA201404920B (en) 2015-12-23
CA2858379A1 (en) 2013-06-13
EA201491010A1 (ru) 2015-01-30
CN104080472A (zh) 2014-10-01
JP2015500836A (ja) 2015-01-08
BR112014013565A2 (pt) 2019-09-24

Similar Documents

Publication Publication Date Title
CN108464981B (zh) 抑制tie2激酶的组合物在制备治疗癌症的药物中的用途
CN109513010B (zh) 肿瘤细胞特异性响应的自组装药物纳米缀合物
US10233221B2 (en) Peptide having eight amino acid sequences derived from cage and retaining anticancer activity and activity to promote anticancer drug sensitivity of anticancer drug-resistant cancer cells
KR101741594B1 (ko) 암세포 및 종양관련 대식세포를 동시에 표적하는 융합 펩타이드를 유효성분으로 포함하는 항암 및 암 전이 억제용 약학적 조성물
CN115087727B (zh) 用于癌症治疗的专性厌氧人肠道微生物及其用途
KR20160089523A (ko) 전립선 암 치료용 조성물
EP2687225A1 (en) HIP/PAP protein and derivatives thereof for use in treating cancer
EP3470078A1 (en) Composition using slit-robo system for preventing or treating sarcopenia
KR20190021765A (ko) 멜리틴을 포함하는 m2형 종양관련 대식세포 제거용 조성물
CN107106645A (zh) 用于治疗c‑met相关性癌症的方法和组合物
US20110158936A1 (en) Use of interleukin 17e for the treatment of cancer
KR102261371B1 (ko) CP2c 표적 펩티드 기반 항암제
KR20140104474A (ko) 종양 성장의 억제 또는 예방에 사용하기 위한 오스테오폰틴 변이체 및 상기 오스테오폰틴 변이체를 함유하는 조성물
US20150190460A1 (en) Osteopontin peptide fragments for use in suppression or prevention of tumor growth
US20230414712A1 (en) Pharmaceutical composition for preventing or treating cancer comprising recombinant stabilized galectin 9 protein
WO2019086507A1 (en) Immunotherapeutic methods for treating and/or preventing lung cancer
KR20200108494A (ko) 근위축성 측삭 경화증 치료제
EP3824901A1 (en) Pharmaceutical composition and use for applying ganoderma microsporum immunomodulatory protein and keyhole limpet hemocyanin in carcinoma treatment
CA2832376A1 (en) Drug containing recombinant mistletoe lectins for treating malignant melanoma
KR20200104830A (ko) 알부민이 결합된, Slit3 단백질의 LRRD2를 포함하는 골 관련 질환 예방 또는 치료용 조성물
KR20170135544A (ko) 간질환 예방 또는 치료용 펩타이드 및 이를 유효성분으로 포함하는 조성물
KR101552021B1 (ko) Rab5 발현 저해 물질을 유효 성분으로 포함하는 파브리 질환의 예방 또는 치료용 조성물
EP4005583A1 (en) Cp2c-targeting peptide-based anticancer agent
KR101608141B1 (ko) 클라스린 발현 저해 물질을 유효 성분으로 포함하는 파브리 질환의 예방 또는 치료용 조성물
KR20250156270A (ko) 지방간의 예방 또는 치료 활성을 갖는 펩타이드 복합체 및 이의 용도

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20140704

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid